Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cross-reactivity00:42

Cross-reactivity

Overview
Allergic Reactions02:06

Allergic Reactions

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted versus Universally Offered Screening in Pediatric Emergency Departments: Cost-Effectiveness.

MDM policy & practice·2026
Same author

An Ounce of Prevention and a Pound of Cardiac Rehabilitation.

The Canadian journal of cardiology·2026
Same author

Hypertensive responses to exercise after 12-weeks of high-intensity interval training or moderate-to-vigorous intensity continuous training in patients with persistent and permanent atrial fibrillation: a non-prespecified post-hoc analysis of a randomized clinical trial.

Journal of science and medicine in sport·2026
Same author

A Glass Half-Full: Physical Activity Discussions Between Health Care Professionals and Patients With Atrial Fibrillation.

The Canadian journal of cardiology·2026
Same author

Reply to Soliman et al, Rapid HCV diagnostics: aligning molecular innovation with real-world elimination needs.

The Journal of infectious diseases·2026
Same author

Combined strength and aerobic training vs. aerobic training alone in patients with heart failure: A systematic review and meta-analysis.

Journal of sport and health science·2026
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Eczema vaccinatum.

Jennifer L Reed1, Dorothy E Scott, Mike Bray

  • 1Laboratory of Plasma Derivatives, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20892, USA. jennifer.reed@fda.hhs.gov

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|February 1, 2012
PubMed
Summary
This summary is machine-generated.

Eczema vaccinatum (EV), a severe complication of smallpox vaccination in individuals with eczema/atopic dermatitis (AD), is rare due to vaccination deferral. Understanding EV pathophysiology is crucial for prevention strategies.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

Related Experiment Videos

Last Updated: May 25, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Vaccinology

Background:

  • Eczema vaccinatum (EV) is a severe complication of smallpox vaccination, particularly in individuals with eczema/atopic dermatitis (AD).
  • Defective skin barrier function in AD facilitates vaccinia virus dissemination and systemic illness.
  • Due to vaccination deferral for individuals with AD, EV cases are exceptionally rare.

Purpose of the Study:

  • To review the history of EV during universal smallpox vaccination.
  • To discuss the relationship between EV and other skin conditions.
  • To explore current understanding of AD pathophysiology in relation to EV and identify knowledge gaps.

Main Methods:

  • Literature review of EV during the era of universal vaccination.
  • Analysis of AD pathophysiology, including skin barrier defects and immune responses.
  • Identification of unanswered questions regarding EV.

Main Results:

  • EV is a serious risk for individuals with AD following smallpox vaccination.
  • AD's compromised skin barrier and altered immune system create a favorable environment for vaccinia virus spread.
  • Few EV cases have been documented since the resumption of US military smallpox vaccination.

Conclusions:

  • Understanding the pathophysiology of AD is key to comprehending EV.
  • Further research is needed to address knowledge gaps concerning EV.
  • Strategies to minimize EV occurrence are essential in case of a return to universal vaccination.
  • Main_Methods.1
  • Main_Methods.2
  • Main_Results.0
  • Main_Results.1
  • Main_Results.2
  • Conclusions.0
  • Conclusions.1
  • Conclusions.2